{"id":"https://openalex.org/W4298375439","doi":null,"title":"Investigation of Febrile Neutropenic Cases and Risk Factors","display_name":"Investigation of Febrile Neutropenic Cases and Risk Factors","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W4298375439"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:e29258d8920646daa9298136a7cf990e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e29258d8920646daa9298136a7cf990e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 2 (2013)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/e29258d8920646daa9298136a7cf990e","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101732561","display_name":"Mehmet \u00d6zden","orcid":"https://orcid.org/0000-0002-1202-0864","observed_orcids":["https://orcid.org/0000-0002-1202-0864"]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Mehmet \u00d6ZDEN","raw_affiliation_strings":["F\u0131rat \u00dcniversitesi T\u0131p Fak\u00fcltesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Anabilim Dal\u0131, Elaz\u0131\u011f, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F\u0131rat \u00dcniversitesi T\u0131p Fak\u00fcltesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Anabilim Dal\u0131, Elaz\u0131\u011f, T\u00fcrkiye","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078961292","display_name":"Affan Denk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Affan DENK","raw_affiliation_strings":["\u00d6zel Damla Hastanesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Klini\u011fi, Elaz\u0131\u011f, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u00d6zel Damla Hastanesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Klini\u011fi, Elaz\u0131\u011f, T\u00fcrkiye","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111889898","display_name":"Kutbettin Dem\u0131rda\u011f","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143396566","display_name":"F\u0131rat University","ror":"https://ror.org/05teb7b63","country_code":"TR","type":"education","lineage":["https://openalex.org/I143396566"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kutbettin DEM\u0130RDA\u011e","raw_affiliation_strings":["F\u0131rat \u00dcniversitesi T\u0131p Fak\u00fcltesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Anabilim Dal\u0131, Elaz\u0131\u011f, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F\u0131rat \u00dcniversitesi T\u0131p Fak\u00fcltesi, Enfeksiyon Hastal\u0131klar\u0131 ve Klinik Mikrobiyoloji Anabilim Dal\u0131, Elaz\u0131\u011f, T\u00fcrkiye","institution_ids":["https://openalex.org/I143396566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085152481","display_name":"Tamer E. Elkiran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20126385","display_name":"Inonu University","ror":"https://ror.org/04asck240","country_code":"TR","type":"education","lineage":["https://openalex.org/I20126385"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Tamer ELKIRAN","raw_affiliation_strings":["\u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi, T\u0131bbi Onkoloji Anabilim Dal\u0131, Malatya, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi, T\u0131bbi Onkoloji Anabilim Dal\u0131, Malatya, T\u00fcrkiye","institution_ids":["https://openalex.org/I20126385"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3308,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.6439871,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":1.0},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.9430000185966492},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7020000219345093},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.996999979019165},{"id":"https://openalex.org/keywords/site-of-infection","display_name":"infection site","score":0.3880000114440918},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pyelonephritis","display_name":"pyelonephritis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gram-negative-bacilli","display_name":"Gram-negative bacilli","score":0.8999999761581421},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.984000027179718},{"id":"https://openalex.org/keywords/candida","display_name":"Candida","score":0.8629999756813049},{"id":"https://openalex.org/keywords/empirical-antimicrobial-therapy","display_name":"empirical antimicrobial therapy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/cefoperazone-sulbactam","display_name":"cefoperazone/sulbactam","score":0.9760000109672546},{"id":"https://openalex.org/keywords/fever-of-unknown-origin","display_name":"fever of unknown origin","score":0.8619999885559082},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.592533528804779},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.526470422744751},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48291727900505066},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.2654782235622406},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21606579422950745},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.06431373953819275}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:doaj.org/article:e29258d8920646daa9298136a7cf990e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e29258d8920646daa9298136a7cf990e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 2 (2013)","raw_type":"article"},{"id":"pmh:oai:openaccess.firat.edu.tr:11508/50489","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11508/50489","pdf_url":null,"source":{"id":"https://openalex.org/S4377196733","display_name":"DSpace - FIRAT (F\u0131rat University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I143396566","host_organization_name":"F\u0131rat University","host_organization_lineage":["https://openalex.org/I143396566"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:e29258d8920646daa9298136a7cf990e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e29258d8920646daa9298136a7cf990e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 2 (2013)","raw_type":"article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4226148723","https://openalex.org/W3012269012","https://openalex.org/W4413786695","https://openalex.org/W2766330002","https://openalex.org/W2159917368","https://openalex.org/W7217213847","https://openalex.org/W2213927336","https://openalex.org/W3031784818","https://openalex.org/W4321480431","https://openalex.org/W4200588738"],"abstract_inverted_index":{"Introduction:":[0],"Febrile":[1],"neutropenia":[2,252],"is":[3],"one":[4],"of":[5,47,57,68,102,124,131,166,211,236,245,269,278],"the":[6,44,53,58,69,92,103,107,115,125,148,180,201,246,250,267],"most":[7,170,202,221],"important":[8,285],"factors":[9],"responsible":[10],"for":[11,95],"morbidity":[12],"and":[13,19,37,62,84,128,141,162,176,182,194,216,256],"mortality":[14],"in":[15,28,52,81,87,98,106,114,206,226,263,271,286],"cancer":[16],"patients.":[17,89],"Materials":[18],"Methods:":[20],"In":[21],"this":[22],"study,":[23],"febrile":[24,251,274],"neutropenic":[25,126,150],"attacks":[26],"seen":[27],"100":[29,149],"patients":[30,59,70,83,104,112,212,247,272],"who":[31],"were":[32,40,60,64,78,105,113,133,153,158,164,174,228],"consulted":[33],"between":[34],"January":[35],"2008":[36],"December":[38],"2009":[39],"retrospectively":[41],"evaluated.":[42],"Only":[43],"first":[45],"attack":[46],"each":[48],"patient":[49],"was":[50,71,200,239],"included":[51,187,213],"study.":[54],"Results:":[55],"Fifty-eight":[56],"female":[61],"42":[63],"male.":[65],"Mean":[66,118,230],"age":[67],"59.4":[72],"+/-":[73,135,138,143,241],"13.4":[74],"years.":[75],"Primary":[76],"malignancies":[77],"hematologic":[79],"malignancy":[80],"30":[82],"solid":[85],"tumors":[86],"70":[88],"According":[90],"to":[91,265,283],"Multinational":[93],"Association":[94],"Supportive":[96],"Care":[97],"Cancer":[99],"criteria,":[100],"29":[101],"low-risk":[108],"group,":[109],"whereas":[110],"71":[111],"high-risk":[116],"group.":[117],"absolute":[119],"neutrophil":[120],"count,":[121],"mean":[122,129],"duration":[123,130],"period":[127],"hospitalization":[132],"247.8":[134],"25.2/mm(3),":[136],"3.3":[137],"1.9":[139],"days":[140],"4.4":[142],"0.7":[144],"days,":[145],"respectively.":[146],"Of":[147],"attacks,":[151],"22":[152],"clinically":[154],"defined":[155,160],"infection,":[156],"39":[157,163],"microbiologically":[159],"infection":[161,172,270],"fever":[165,231],"unknown":[167],"origin.":[168],"The":[169,220],"frequent":[171],"sites":[173],"pneumonia":[175],"pyelonephritis":[177],"based":[178],"on":[179],"clinical":[181],"microbiological":[183,257],"findings.":[184],"Isolated":[185],"strains":[186],"44":[188],"gram-negative":[189],"bacilli,":[190],"four":[191],"gram-positive":[192],"cocci":[193],"nine":[195],"Candida":[196],"spp.":[197],"Escherichia":[198],"coli":[199],"frequently":[203,222],"isolated":[204],"agent":[205],"these":[207],"strains.":[208],"Empirical":[209],"treatment":[210,238,281],"monotherapy":[214,227],"(61%)":[215],"combined":[217],"therapy":[218],"(39%).":[219],"used":[223],"antimicrobial":[224,280],"agents":[225],"cefoperazone-sulbactam.":[229],"defervescence":[232],"time":[233],"after":[234],"initiation":[235,277],"empirical":[237],"2.6":[240],"0.2":[242],"days.":[243],"Fifteen":[244],"died":[248],"during":[249],"attack.":[253],"Conclusion:":[254],"Clinical":[255],"approaches":[258],"should":[259],"be":[260,284],"made":[261],"carefully":[262],"order":[264],"determine":[266],"focus":[268],"with":[273],"neutropenia.":[275],"Early":[276],"empiric":[279],"seems":[282],"reducing":[287],"mortality.":[288]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2022-10-02T00:00:00"}